Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package GlobeNewswire December 17, 2025 Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial Flexibility BroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board on Growth and Operating Opportunities HOLLISTON, Mass., Dec. 17, […]

Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates GlobeNewswire December 17, 2025 WATERTOWN, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) — Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology

Alliance Police Department Commits to Non-Lethal Response with Full BolaWrap(R) 150 Rollout GlobeNewswire December 17, 2025 MIAMI, Dec. 17, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in non-lethal response and public-safety technology solutions, today announced that the Alliance Police Department (“Alliance PD”) has partnered with Wrap

Cytokinetics Announces NMPA Approval of MYQORZO(R) (aficamten) in China for Patients with Obstructive Hypertrophic Cardiomyopathy GlobeNewswire December 17, 2025 Approval Triggers Milestone Payment of $7.5 Million from Sanofi; Cytokinetics Eligible to Receive Additional Milestone Payments and Royalties on Net Sales in Greater China SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated

Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference GlobeNewswire December 17, 2025 BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will present at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026. Presentation

Beyond Air(R) Signs New International LungFit PH(R) Distribution Agreements, Most Notably in Germany and Brazil Distribution network coverage expanded to a total of 39 countries GlobeNewswire December 17, 2025 GARDEN CITY, N.Y., Dec. 17, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical

Renowned AI Expert Xi Chen Joins Compass Lexecon GlobeNewswire December 17, 2025 WASHINGTON, Dec. 17, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that Dr. Xi Chen, Professor and Andre Meyer Faculty Fellow at the Department of Technology, Operations and Statistics at the New York University Stern School of Business, has affiliated

Nayax Partners with Unipaas to Launch Fully Integrated Card-Present Payments Solution for UK SaaS Platforms GlobeNewswire December 17, 2025 HERZLIYA, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments, and loyalty platform designed to help merchants scale their business, today announced its strategic partnership with Unipaas,

Terra Innovatum Advances NRC Licensing of SOLO(TM) Reactor Licensing Through Expanded Regulatory Submissions New SOLO(TM) Micro-Modular Reactor Submissions Advance Licensing as Low-Consequence Regulatory Framework Takes Shape GlobeNewswire December 17, 2025 NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — Terra Innovatum Global N.V. (“Terra Innovatum” or the “Company“) (NASDAQ: NKLR), a developer of micro-modular nuclear reactors

Bombardier Announces $500 Million Debt Repayment and Confirms Deleveraging Plan on Target GlobeNewswire December 17, 2025 MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) — Bombardier today confirmed the company is on track to reach its previously stated net leverage ratio target of 2.0-2.5x. With the $500 million debt redemption notice announced on December 17, which is